Kalshi's rapid expansion has run into a question about paperwork with potentially serious consequences: did it properly tell its federal regulator about the products it planned to offer? The Commodity Futures Trading Commission has warned the prediction-market operator about possible enforcement charges, according to a November 10 report.

The warning comes less than two weeks after Kalshi announced a $1 billion funding round at a $40 billion valuation. The company is trying to turn its success in event trading into a broader financial exchange, with new products and institutional customers central to that plan.

Regulators question the filings

Politico reported, citing a person with direct knowledge of the investigation, that the CFTC was examining whether Kalshi failed to properly notify it about dozens of new products. Reuters subsequently carried the account. The reported warning signals potential charges, rather than an announced finding that the company broke the law.

Kalshi disputed the scale of the problem. Spokesperson Elisabeth Diana described it as a procedural error involving submissions for a handful of contracts, many of which weren't live, in a statement reported by Politico.

We are already addressing the issue.

That response puts the disagreement around the filing process and the number of affected contracts. It also makes an important distinction for customers: a proposed contract and a market already open for trading aren't the same thing.

The rule behind the dispute

Federally regulated exchanges can introduce products through self-certification, without waiting for an affirmative approval for every individual contract. But they must first submit the required information and certify that the product meets federal law and CFTC regulations.

Commission Regulation 40.2 requires receipt of the submission by the opening of business on the business day before listing. The filing must include contract terms, the intended launch date and a complete explanation of compliance, backed by documentation or cited data.

The agency had already raised concerns about how event contracts were being submitted. In a July 24 advisory, its Division of Market Oversight explained:

The advisory addresses concerns about the practice of submitting broad, template-style certifications that combine many potential event contract variations into a single certification.

Staff said those filings limited its ability to assess settlement methods, data sources and compliance with the exchange's core obligations. The guidance also explained when closely related contracts could be certified together. It addressed industry practices generally, without naming Kalshi as a violator.

Growth depends on more markets

Kalshi's own announcement on October 29 shows the scale of its ambitions. Wellington and Sequoia co-led the $1 billion Series G, with investors including Baillie Gifford, Andreessen Horowitz, Coatue and Morgan Stanley Investment Management.

The company reported more than $1 billion in non-sports annualized revenue and annualized trading volume above $1 trillion across its overall business. Those are company-reported run rates, not completed full-year results. It also said more than 30 million accounts had been created, a measure that doesn't establish how many people actively trade.

Sports helped bring millions of customers onto the platform, Kalshi said. Its expansion now covers politics, crypto, commodities and perpetual futures. Commodities alone had reached more than $100 million in annualized trading fees within three months, according to the company.

The funding is intended to support institutional sales, international expansion and new products, including indices, single-stock perpetual futures and computing markets. Kalshi identified Latin America and Europe as priorities for its international business.

The CFTC's rules also allow staff to request additional evidence, information or data showing a contract meets legal requirements, both initially and on an ongoing basis. Exchanges must publish notice of a pending certification and a copy of the submission on their own websites when they file with the regulator. The rules permit requests for confidential treatment where appropriate.